Utility of an extended 12-autoantibody panel in systemic sclerosis: clinical and prognostic implications in a real-life cohort

P. López de Turiso Giner, L. Fumanal Idocin, L. Martínez-Lostao, L. Corredor Sánchez, L. Sáez Cómet, J. Velilla Marco

Open source

DOI
10.1016/j.rceng.2026.502620
Published
2026-09
Container
Revista Clínica Española (English Edition)
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rceng.2026.502620,
  title = {Utility of an extended 12-autoantibody panel in systemic sclerosis: clinical and prognostic implications in a real-life cohort},
  author = {P. López de Turiso Giner and L. Fumanal Idocin and L. Martínez-Lostao and L. Corredor Sánchez and L. Sáez Cómet and J. Velilla Marco},
  year = {2026},
  journal = {Revista Clínica Española (English Edition)},
  doi = {10.1016/j.rceng.2026.502620},
  url = {https://doi.org/10.1016/j.rceng.2026.502620}
}

RIS

TY  - JOUR
TI  - Utility of an extended 12-autoantibody panel in systemic sclerosis: clinical and prognostic implications in a real-life cohort
AU  - P. López de Turiso Giner
AU  - L. Fumanal Idocin
AU  - L. Martínez-Lostao
AU  - L. Corredor Sánchez
AU  - L. Sáez Cómet
AU  - J. Velilla Marco
PY  - 2026
JO  - Revista Clínica Española (English Edition)
DO  - 10.1016/j.rceng.2026.502620
UR  - https://doi.org/10.1016/j.rceng.2026.502620
ER  - 

APA

Giner, P. L. D. T., Idocin, L. F., Martínez-Lostao, L., Sánchez, L. C., Cómet, L. S., & Marco, J. V. (2026). Utility of an extended 12-autoantibody panel in systemic sclerosis: clinical and prognostic implications in a real-life cohort. Revista Clínica Española (English Edition). https://doi.org/10.1016/j.rceng.2026.502620

Source records